Shares of Novo Nordisk and rival Eli Lilly fell on Tuesday after a report said price cuts are coming for popular weight-loss drugs.
Source link
#Novo #Nordisk #Eli #Lilly #shares #fall #Novos #pricecut #plan #Ozempic #Wegovy
Trending
- Samsung Galaxy Unpacked live — Galaxy S26 Ultra and what else to expect
- At a 15-year high, can Tesco shares still offer any value?
- SriLankan Airlines announces Ahmedabad as its 10th destination in India
- Snoop Dogg to attend first Swansea game after Winter Olympics trip
- ‘American Idol’ Contestant Dimitrius Graham Arrested in Los Angeles
- Investors seek shelter from AI rout in asset-heavy stocks
- Fed’s Goolsbee calls for a hold on cuts as current rate of inflation is ‘not good enough’
- Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients
Novo Nordisk and Eli Lilly shares both fall after Novo’s price-cut plan for Ozempic and Wegovy
By V. Alure
